abstract |
Formula I for the manufacture of a medicament for the treatment of diseases where inhibition of the activity of members of the MAPEG family is desired and / or required, particularly for the treatment of inflammation: [Chemical 1] [Wherein Y, W 1 to W 4 , Z 1 to Z 4 and R have the meanings given in this description] And the use of pharmaceutically acceptable salts thereof. |